UROLOGICAL CANCER Chemoradiation superior in muscle-invasive bladder cancer

被引：2
|
作者：
Weiss, Christian [1 ]
Roedel, Claus [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Radiat Therapy & Oncol, D-60590 Frankfurt, Germany
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2012年 / 9卷 / 07期
关键词：
SELECTIVE ORGAN PRESERVATION; RADICAL CYSTECTOMY; RADIOTHERAPY; CHEMOTHERAPY; EXPERIENCE; THERAPY;
D O I：
10.1038/nrclinonc.2012.92
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Multimodal organ-sparing treatment strategies have shown similar survival rates when compared to radical surgery for muscle-invasive bladder cancer; however, up to 80% of surviving patients retained their own, well-functioning bladder. Within an interdisciplinary bladder-preserving treatment protocol, concurrent chemoradiotherapy was superior to radiotherapy alone-supporting its use as an alternative to radical cystectomy. © 2012 Macmillan Publishers Limited. All rights reserved.
引用
收藏
页码：374 / 375
页数：3
相关论文
共 50 条
  • [21] Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer
    McPherson, Victor A.
    Rodrigues, George
    Bauman, Glenn
    Winquist, Eric
    Chin, Joseph
    Izawa, Jonathan
    Potvin, Kylea
    Ernst, Scott
    Venkatesan, Varagur
    Sexton, Tracy
    Ahmad, Belal
    Power, Nicholas
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (1-2): : 24 - 30
  • [22] Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
    Witjes, J. Alfred
    Feikema, Astrid A. H.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7833 - 7839
  • [23] Practice-changing publications: Muscle-invasive bladder cancer
    Aminoltejari, Khatereh
    Kulkarni, Girish
    Mason, Ross
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (01): : E57 - E60
  • [24] Is trimodal therapy the current standard for muscle-invasive bladder cancer?
    Valcarcel, M. Lopez
    Los Arcos, M. Barrado
    Molina, M. Ferri
    Belmonte, I. Cienfuegos
    Santana, V. Duque
    Borau, P. Gajate
    Ibiza, J. Fernandez
    Maestro, M. alvarez
    Sargos, P.
    Campos, F. Lopez
    Counago, F.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (05): : 345 - 355
  • [25] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17
  • [26] Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
    Ploussard, Guillaume
    Daneshmand, Siamak
    Efstathiou, Jason A.
    Herr, Harry W.
    James, Nicholas D.
    Roedel, Claus M.
    Shariat, Shahrokh F.
    Shipley, William U.
    Sternberg, Cora N.
    Thalmann, George N.
    Kassouf, Wassim
    EUROPEAN UROLOGY, 2014, 66 (01) : 120 - 137
  • [27] Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer
    Elumalai, Thiraviyam
    Joseph, Nuradh
    Choudhury, Ananya
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (01) : 56 - 61
  • [28] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [29] Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
    Koga, Fumitaka
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 981 - 982
  • [30] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
12345